mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.8 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |